Erudio Healtherudio.com
Drug
Busulfan trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying busulfan: BMT CTN 0901. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 2 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| BMT CTN 0901 NCT01339910 · Medical College of Wisconsin | acute myeloid leukemia or myelodysplastic syndrome | Phase 3 | 91 | 23 | Focused | Oct 31, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| OPTIMIZE NCT06001385 · Center for International Blood and Marrow Transplant Research FocusedView → | hematologic malignancies receiving HLA-mismatched unrelated donor transplantation | Phase 2 | Focused | View | |||
| ACCESS NCT04904588 · Center for International Blood and Marrow Transplant Research FocusedView → | hematologic malignancies | Phase 2 | Focused | View | |||